Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23273164)

1.

Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma.

Price D, Bousquet J.

Respir Med. 2012 Dec;106 Suppl 1:S4-8. doi: 10.1016/S0954-6111(12)70004-5. Review.

2.

Stepping Up Asthma Therapy in the "Real World".

Nyenhuis SM, Krishnan JA.

Ann Am Thorac Soc. 2015 Jun;12(6):789-90. doi: 10.1513/AnnalsATS.201504-225ED. No abstract available.

PMID:
26075550
3.

Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study.

Turner SW, Richardson K, Burden A, Thomas M, Murray C, Price D.

NPJ Prim Care Respir Med. 2015 Jun 11;25:15041. doi: 10.1038/npjpcrm.2015.41.

PMID:
26068328
4.

Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma.

Ricciardolo FL, Blasi F, Centanni S, Rogliani P.

Pulm Pharmacol Ther. 2015 May 23. pii: S1094-5539(15)00051-6. doi: 10.1016/j.pupt.2015.05.006. [Epub ahead of print]

PMID:
26014510
5.

Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.

Israel E, Roche N, Martin RJ, Colice G, Dorinsky PM, Postma DS, Guilbert TW, van Aalderen WM, Grigg J, Hillyer EV, Burden A, von Ziegenweidt J, Thomas V, Price DB.

Ann Am Thorac Soc. 2015 Jun;12(6):798-806. doi: 10.1513/AnnalsATS.201412-580OC.

PMID:
25756308
6.

Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases.

Giembycz MA, Newton R.

F1000Prime Rep. 2015 Feb 3;7:16. doi: 10.12703/P7-16. eCollection 2015. Review.

7.

Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice.

Dissanayake SB.

AAPS J. 2015 May;17(3):754-7. doi: 10.1208/s12248-015-9734-8. Epub 2015 Feb 25.

PMID:
25712726
8.
9.

Management of asthma in resource-limited settings: role of low-cost corticosteroid/β-agonist combination inhaler.

Chiang CY, Aït-Khaled N, Bissell K, Enarson DA.

Int J Tuberc Lung Dis. 2015 Feb;19(2):129-36. doi: 10.5588/ijtld.14.0363.

PMID:
25574908
10.

AIMAR survey on complex forms of bronchial asthma and COPD, their management and perception of critical issues.

Donner CF, Visconti A.

Multidiscip Respir Med. 2014 Oct 28;9(1):52. doi: 10.1186/2049-6958-9-52. eCollection 2014.

11.

β2-agonists for the prevention of exercise-induced asthma.

Shi C.

Am J Nurs. 2014 Sep;114(9):23. doi: 10.1097/01.NAJ.0000453749.08517.ec. Review. No abstract available.

PMID:
25166243
12.

Study of asthma management practices among general practitioners and physicians in and around Pune city.

Barthwal MS, Pethe MP.

J Indian Med Assoc. 2013 Dec;111(12):840-4.

PMID:
25154158
13.

Asthma management among different specialists: results from a national Italian survey.

Caminati M, Magnoni MS, Rizzi A, Braido F, Foresi A, Bettoncelli G, Infantino A, D'Andria C, Antonicelli L, Paggiaro PL, Falcone F, Senna G.

Eur Ann Allergy Clin Immunol. 2014 Mar;46(2):74-82.

PMID:
24739126
14.

Inappropriate prescribing of combination inhalers in Northern Ireland: retrospective cross-sectional cohort study of prescribing practice in primary care.

Sweeney J, Patterson CC, O'Neill S, O'Neill C, Plant G, Lynch V, McAllister T, Heaney LG.

Prim Care Respir J. 2014 Mar;23(1):74-8. doi: 10.4104/pcrj.2014.00007.

15.

Changes to inhaled corticosteroid dose when initiating combination inhaler therapy in long-acting β agonist-naïve patients with asthma: a retrospective database analysis.

Covvey JR, Johnston BF, Wood F, Boyter AC.

Thorax. 2014 Nov;69(11):1056-8. doi: 10.1136/thoraxjnl-2013-204944. Epub 2014 Jan 15.

PMID:
24430175
16.

Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review.

Eltonsy S, Kettani FZ, Blais L.

Respir Med. 2014 Jan;108(1):9-33. doi: 10.1016/j.rmed.2013.07.009. Epub 2013 Dec 17. Review.

PMID:
24360293
17.

Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines.

Bousquet J, Busse WW.

World Allergy Organ J. 2010 Feb 15;3(2):16-22. doi: 10.1097/WOX.0b013e3181cb90c3.

18.

Authors' reply to 'Safety and tolerability of fluticasone furoate/vilanterol'.

Busse WW, Andersen L.

Thorax. 2013 Dec;68(12):1165-6. doi: 10.1136/thoraxjnl-2013-203992. Epub 2013 Jul 2. No abstract available.

PMID:
24204004
19.

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.

Griffiths B, Ducharme FM.

Paediatr Respir Rev. 2013 Dec;14(4):234-5. doi: 10.1016/j.prrv.2013.08.002. Epub 2013 Sep 24. Review. No abstract available.

PMID:
24070913
20.

Systemic safety of fluticasone furoate/vilanterol combination.

Lipworth B.

Thorax. 2013 Dec;68(12):1165. doi: 10.1136/thoraxjnl-2013-203910. Epub 2013 Jul 2. No abstract available.

PMID:
23821392
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk